Latest News
- CIRM grant will help expand patients’ access to innovative UCLA clinical trials
A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-section of Los Angeles’ diverse population in potentially lifesaving medical research.
October 28, 2022 12:00 PM
detail - UCLA post-doctoral scholar receives award to search for genetic clues to predict prostate cancer aggressiveness
Roni Haas has received the 2022 Todd Boehly-PCF Young Investigator Award from the Prostate Cancer Foundation to support her prostate cancer research project.
October 26, 2022 9:00 AM
detail - New analysis finds timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer
A new UCLA study shows that it is almost universally optimal for men to begin androgen deprivation therapy when starting radiation therapy for prostate cancer.
October 21, 2022 12:00 PM
detail - UCLA researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme
Research led by UCLA doctors and scientists has identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme (GBM).
October 20, 2022 10:00 AM
detail - Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy
A new UCLA Health study finds a clue that could help reduce serious neurological side effects associated with CAR T-cell therapy known as immune effector cell-associated neurotoxicity syndrome (ICANS).
October 19, 2022 8:00 AM
detail - UCLA's Michael Grunstein wins 2022 Albany Prize for groundbreaking research
Michael Grunstein, distinguished professor emeritus of biological chemistry at the David Geffen School of Medicine at UCLA, has been awarded the 2022 Albany Prize for his groundbreaking research on gene expression.
October 13, 2022 10:00 AM
detail - Patient care goes hand in hand with clinical research for these gynecologic oncologists
Meet three UCLA gynecologic oncologists who are leading groundbreaking research aimed at the clinical challenges they encounter while providing direct patient care through every stage of treatment.
October 10, 2022 9:00 AM
detail - Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors
A new long-term study of older breast cancer survivors published in the Journal of Clinical Oncology and co-led by UCLA researchers adds important evidence to that potential link.
September 29, 2022 1:00 PM
detail - UCLA Oncologist Receives 2022 Ellen Stovall Award
Dr. Patricia Ganz has been awarded the 2022 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care.
September 29, 2022 9:00 AM
detail - Two early cancer detection programs boosted by renewed NCI grants
The National Cancer Institute has renewed funding for two collaborative programs through which UCLA Jonsson Comprehensive Cancer Center researchers are developing new biomarkers for earlier detection and more effective treatment of cancers.
September 26, 2022 9:00 AM
detail - Research led by UCLA’s Jonsson Comprehensive Cancer Center tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples
UCLA researchers and collaborating organizations report successful results from an experimental cancer-detection system that appears to have overcome these challenges in a novel, cost-effective way.
September 23, 2022 10:00 AM
detail - Cell therapy could improve bone marrow transplant safety
UCLA researchers report a step forward in the development of an “off-the-shelf” cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment of blood cancers such as leukemia and lymphoma.
September 12, 2022 9:00 AM
detail - Antoni Ribas receives renewal of NCI Outstanding Investigator Award
Dr. Antoni Ribas has received a renewal of an Outstanding Investigator Award from the National Cancer Institute to fund his innovative research on metastatic melanoma.
September 07, 2022 9:00 AM
detail